Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
With major pharmaceutical companies recently withdrawing from the UK and concern about the current reimbursement model, according to the Financial Times, the government is set to alter the pricing structure
A 2024 Diabetes, Obesity and Metabolism study on a small-molecule NNMT inhibitor found it dose-dependently limited body weight and fat mass gains, improved oral glucose tolerance and insulin sensitivity, and suppressed hyperinsulinaemia in obese mice (PMID 39161060) [6]
Losing weight during menopause During menopause, the hormonal balance in the body changes, directly affecting weight and metabolism
Target Consumer Segments Adults With Weight Management Goals (2550) : men and women seeking therapeutic supplementation for appetite regulation, fat metabolism, and sustainable weight loss Adults With Pre-diabetes Or Type 2 Diabetes (3060) : individuals requiring preventative and therapeutic support for blood sugar control and improved insulin sensitivity Obese And Overweight Consumers (2555) : adults addressing obesity-related health risks who benefit from GLP-1 booster supplementation for metabolic balance Seniors (55+) : older adults managing slower metabolism and cardiovascular health who require preventative supplementation for healthy aging and weight control Fitness Enthusiasts (2040) : active adults and athletes seeking appetite management, sustained energy, and recovery benefits from GLP-1 support Patients In Recovery : individuals overcoming chronic metabolic disorders or post-treatment fatigue who benefit from therapeutic supplementation for stabilization and resilience Regional Consumer Demand North America Market Insight : North America has a rapidly growing market for weight management and blood sugar control supplements, with a focus on natural, clinically-supported products
US$ 23.51
US$ 29.62
US$ 26.43
US$ 20.54
